DENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Book value per share
DENTSPLY SIRONA Inc.'s book value per share at the end of fiscal 2025 was 6.7×, down 29.7% from 9.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 6.8×. Over the past ten years it has ranged from 6.7× (fiscal 2025) to 37.3× (fiscal 2016) — the current reading is the lowest in ten years. DENTSPLY SIRONA Inc. ranks 28th of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 6.7× | (29.72%) |
| FY2024 | 9.6× | (38.46%) |
| FY2023 | 15.5× | (12.16%) |
| FY2022 | 17.7× | (22.69%) |
| FY2021 | 22.9× | 1.63% |
| FY2020 | 22.5× | (1.42%) |
| FY2019 | 22.8× | (0.21%) |
| FY2018 | 22.9× | (20.79%) |
| FY2017 | 28.9× | (22.49%) |
| FY2016 | 37.3× | 123.07% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 6.8× | 0.47% |
| Jun 2026 | 6.8× | 2.53% |
| Mar 2026 | 6.6× | (1.81%) |
| Dec 2025 | 6.7× | (9.29%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| AZTA Azenta, Inc. compare | 33.3× |
| LMAT LeMaitre Vascular, Inc. compare | 18.9× |
| ATRC AtriCure, Inc. compare | 10.9× |
| STAA STAAR Surgical Company compare | 7.4× |
| XRAY DENTSPLY SIRONA Inc. | 6.8× |
| STVN Stevanato Group S.p.A. compare | 6.7× |
| KMTS Kestra Medical Technologies, Ltd. compare | 3.8× |
| WRBY Warby Parker Inc. compare | 3.2× |
| PLSE Pulse Biosciences, Inc compare | 2.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement